1. Home
  2. CHRS vs SGC Comparison

CHRS vs SGC Comparison

Compare CHRS & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.27

Market Cap

209.8M

Sector

Health Care

ML Signal

HOLD

Logo Superior Group of Companies Inc.

SGC

Superior Group of Companies Inc.

HOLD

Current Price

$14.08

Market Cap

192.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHRS
SGC
Founded
2010
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
209.8M
192.8M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
CHRS
SGC
Price
$1.27
$14.08
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$5.51
$16.00
AVG Volume (30 Days)
690.4K
44.1K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
4.93%
EPS Growth
472.00
N/A
EPS
N/A
0.14
Revenue
N/A
$566,184,000.00
Revenue This Year
$73.08
$3.23
Revenue Next Year
$30.94
$3.82
P/E Ratio
N/A
$100.93
Revenue Growth
N/A
0.09
52 Week Low
$0.83
$8.30
52 Week High
$2.62
$14.59

Technical Indicators

Market Signals
Indicator
CHRS
SGC
Relative Strength Index (RSI) 35.60 61.28
Support Level $1.15 $9.76
Resistance Level $1.44 $14.59
Average True Range (ATR) 0.08 0.65
MACD -0.01 0.14
Stochastic Oscillator 34.01 84.71

Price Performance

Historical Comparison
CHRS
SGC

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.

Share on Social Networks: